28 results on '"Kinga Gawel"'
Search Results
2. Discovery of (
- Author
-
Michał, Abram, Marcin, Jakubiec, Katelyn, Reeb, Mary Hongying, Cheng, Robin, Gedschold, Anna, Rapacz, Szczepan, Mogilski, Katarzyna, Socała, Dorota, Nieoczym, Małgorzata, Szafarz, Gniewomir, Latacz, Bartłomiej, Szulczyk, Justyna, Kalinowska-Tłuścik, Kinga, Gawel, Camila V, Esguerra, Elżbieta, Wyska, Christa E, Müller, Ivet, Bahar, Andréia C K, Fontana, Piotr, Wlaź, Rafał M, Kamiński, and Krzysztof, Kamiński
- Subjects
Molecular Docking Simulation ,Mice ,Epilepsy ,Seizures ,Animals ,Pentylenetetrazole ,Anticonvulsants - Published
- 2022
3. Isoquinoline Alkaloids from
- Author
-
Sylwia, Nakonieczna, Aneta, Grabarska, Kinga, Gawel, Paula, Wróblewska-Łuczka, Arkadiusz, Czerwonka, Andrzej, Stepulak, and Wirginia, Kukula-Koch
- Subjects
Coptis chinensis ,Berberine ,Methanol ,Berberine Alkaloids ,Water ,Isoquinolines ,Alkaloids ,Bromodeoxyuridine ,Stomach Neoplasms ,Solvents ,Animals ,Chloroform ,Hydrochloric Acid ,Cisplatin ,Zebrafish ,Coptis ,Drugs, Chinese Herbal - Abstract
Gastric cancer (GC) has high incidence rates and constitutes a common cause of cancer mortality. Despite advances in treatment, GC remains a challenge in cancer therapy which is why novel treatment strategies are needed. The interest in natural compounds has increased significantly in recent years because of their numerous biological activities, including anti-cancer action. The isolation of the bioactive compounds from
- Published
- 2022
4. Unexpected content of kynurenine in mother’s milk and infant formulas
- Author
-
Marta Marszalek-Grabska, Anna Stachniuk, Paulina Iwaniak, Kinga Gawel, Agata Sumara, Tomasz Kocki, Emilia Fornal, Paweł Milart, Piotr Paluszkiewicz, and Waldemar Turski
- Subjects
Mammals ,Breast Feeding ,Multidisciplinary ,Milk, Human ,Animals ,Humans ,Infant ,Mothers ,Female ,Infant Formula ,Kynurenine ,Rats - Abstract
Mother’s milk is widely recommended as complete food for the offspring in earliest postnatal time. However, the knowledge about detailed composition and the physiological role of bioactive components of breast milk is incomplete. Therefore, the aim of our study was to determine the content of kynurenine (KYN) in human breast milk during lactation and to explore the effects exerted by intragastric KYN administration from birth to weaning on physical and psychomotor development of adult rats. We found that KYN is consistently present in human milk and its content gradually increased from day 4 to 28 after delivery and that it is present in commercial baby formulas in amounts noticeably exceeding its physiological range. Animal studies showed that KYN supplementation resulted in a marked elevation of absorptive surface of rat intestine and in enhanced expression of both, aryl hydrocarbon receptor and G protein-coupled receptor 35 in the intestinal tissue in rats. Moreover, we discovered that KYN administration from birth to weaning resulted in neurobehavioral changes in adult rats. Therefore, we postulate that further research is required to thoroughly understand the function of KYN in early developmental stages of mammals and to ensure the safety of its presence in baby food products.
- Published
- 2022
5. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome
- Author
-
Suresh Poovathingal, Kinga Gawel, Ju Xu, Maria Lorena Cordero-Maldonado, Kamil Grzyb, Wietske van der Ent, Ettore Tiraboschi, Silvia Martina, Jarle Brattespe, Somisetty V. Satheesh, Maximiliano L. Suster, Sarah Heintz, Camila V. Esguerra, and Alexander Skupin
- Subjects
0301 basic medicine ,Epilepsies, Myoclonic ,Epileptogenesis ,0302 clinical medicine ,Gliosis ,RNA-Seq ,GABAergic Neurons ,NEURONS ,Zebrafish ,education.field_of_study ,Neuronal Plasticity ,SEVERE MYOCLONIC EPILEPSY ,Brain ,Electroencephalography ,MOUSE MODEL ,Astrogliosis ,Neurology ,NEUROPEPTIDE-Y ,GABAergic ,Anticonvulsants ,Single-Cell Analysis ,Life Sciences & Biomedicine ,Locomotion ,sodium channel ,medicine.medical_specialty ,Population ,Mutation, Missense ,Clinical Neurology ,Biology ,Real-Time Polymerase Chain Reaction ,Inhibitory postsynaptic potential ,03 medical and health sciences ,Glutamatergic ,Dravet syndrome ,GABAERGIC INTERNEURONS ,Internal medicine ,Fenfluramine ,OSCILLATIONS ,medicine ,Animals ,education ,Cell Proliferation ,Diazepam ,Science & Technology ,Gene Expression Profiling ,SOMATOSTATIN ,Zebrafish Proteins ,zebrafish ,medicine.disease ,biology.organism_classification ,NAV1.1 Voltage-Gated Sodium Channel ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,DENDRITIC ARBORIZATION ,HIPPOCAMPUS ,epileptogenesis ,fenfluramine ,Neurosciences & Neurology ,Neurology (clinical) ,CRISPR-Cas Systems ,Serotonin 5-HT2 Receptor Agonists ,030217 neurology & neurosurgery - Abstract
Objective: To pinpoint the earliest cellular defects underlying seizure onset (epileptogenic period) during perinatal brain development in a new zebrafish model of Dravet syndrome (DS) and to investigate potential disease-modifying activity of the 5HT2 receptor agonist fenfluramine. Methods: We used CRISPR/Cas9 mutagenesis to introduce a missense mutation, designed to perturb ion transport function in all channel isoforms, into scn1lab, the zebrafish orthologue of SCN1A (encoding voltage-gated sodium channel alpha subunit 1). We performed behavioral analysis and electroencephalographic recordings to measure convulsions and epileptiform discharges, followed by single-cell RNA-Seq, morphometric analysis of transgenic reporter-labeled γ-aminobutyric acidergic (GABAergic) neurons, and pharmacological profiling of mutant larvae. Results: Homozygous mutant (scn1labmut/mut ) larvae displayed spontaneous seizures with interictal, preictal, and ictal discharges (mean = 7.5 per 20-minute recording; P < .0001; one-way analysis of variance). Drop-Seq analysis revealed a 2:1 shift in the ratio of glutamatergic to GABAergic neurons in scn1labmut/mut larval brains versus wild type (WT), with dynamic changes in neuronal, glial, and progenitor cell populations. To explore disease pathophysiology further, we quantified dendritic arborization in GABAergic neurons and observed a 40% reduction in arbor number compared to WT (P < .001; n = 15 mutant, n = 16 WT). We postulate that the significant reduction in inhibitory arbors causes an inhibitory to excitatory neurotransmitter imbalance that contributes to seizures and enhanced electrical brain activity in scn1labmut/mut larvae (high-frequency range), with subsequent GABAergic neuronal loss and astrogliosis. Chronic fenfluramine administration completely restored dendritic arbor numbers to normal in scn1labmut/mut larvae, whereas similar treatment with the benzodiazepine diazepam attenuated seizures, but was ineffective in restoring neuronal cytoarchitecture. BrdU labeling revealed cell overproliferation in scn1labmut/mut larval brains that were rescued by fenfluramine but not diazepam. Significance: Our findings provide novel insights into early mechanisms of DS pathogenesis, describe dynamic cell population changes in the scn1labmut/mut brain, and present first-time evidence for potential disease modification by fenfluramine. Keywords: Dravet syndrome; epileptogenesis; fenfluramine; sodium channel; zebrafish. publishedVersion
- Published
- 2020
6. 6-Gingerol, a Major Constituent of
- Author
-
Kinga, Gawel, Wirginia, Kukula-Koch, Nancy Saana, Banono, Dorota, Nieoczym, Katarzyna M, Targowska-Duda, Lidia, Czernicka, Jolanta, Parada-Turska, and Camila V, Esguerra
- Subjects
Epilepsy ,Plant Extracts ,pentylenetetrazole ,Catechols ,Brain ,molecular docking ,Ginger ,zebrafish ,Receptors, N-Methyl-D-Aspartate ,Article ,Seizures ,Larva ,Zingiber officinale ,neurotransmitter profiling ,Animals ,Pentylenetetrazole ,Anticonvulsants ,anticonvulsant activity ,EEG ,Fatty Alcohols ,isolation ,6-gingerol ,Zebrafish ,gamma-Aminobutyric Acid ,seizures - Abstract
Zingiber officinale is one of the most frequently used medicinal herbs in Asia. Using rodent seizure models, it was previously shown that Zingiber officinale hydroethanolic extract exerts antiseizure activity, but the active constituents responsible for this effect have not been determined. In this paper, we demonstrated that Zingiber officinale methanolic extract exerts anticonvulsant activity in the pentylenetetrazole (PTZ)-induced hyperlocomotion assay in larval zebrafish. Next, we isolated 6-gingerol (6-GIN)—a major constituent of Zingiber officinale rhizoma. We observed that 6-GIN exerted potent dose-dependent anticonvulsant activity in the PTZ-induced hyperlocomotion seizure assay in zebrafish, which was confirmed electroencephalographically. To obtain further insight into the molecular mechanisms of 6-GIN antiseizure activity, we assessed the concentration of two neurotransmitters in zebrafish, i.e., inhibitory γ-aminobutyric acid (GABA) and excitatory glutamic acid (GLU), and their ratio after exposure to acute PTZ dose. Here, 6-GIN decreased GLU level and reduced the GLU/GABA ratio in PTZ-treated fish compared with only PTZ-bathed fish. This activity was associated with the decrease in grin2b, but not gabra1a, grin1a, gria1a, gria2a, and gria3b expression in PTZ-treated fish. Molecular docking to the human NR2B-containing N-methyl-D-aspartate (NMDA) receptor suggests that 6-GIN might act as an inhibitor and interact with the amino terminal domain, the glutamate-binding site, as well as within the ion channel of the NR2B-containing NMDA receptor. In summary, our study reveals, for the first time, the anticonvulsant activity of 6-GIN. We suggest that this effect might at least be partially mediated by restoring the balance between GABA and GLU in the epileptic brain; however, more studies are needed to prove our hypothesis.
- Published
- 2021
7. N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
- Author
-
Piotr Wlaź, Kinga Gawel, Camila V. Esguerra, Katarzyna Socała, Michał Abram, Dorota Nieoczym, Mirosław Zagaja, Bartłomiej Szulczyk, Gniewomir Latacz, Krzysztof Kamiński, Jarogniew J. Łuszczki, Aleksandra Szewczyk, Annamaria Lubelska, Mateusz Pieróg, Marta Andres-Mach, Marcin Jakubiec, and Anna Rapacz
- Subjects
0301 basic medicine ,Male ,isobolographic studies ,Levetiracetam ,Pyrrolidines ,ADME-Tox properties ,medicine.medical_treatment ,Drug-resistant epilepsy ,Pharmacology ,PTZ-kindling model of epilepsy ,03 medical and health sciences ,Epilepsy ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,drug-resistant epilepsy ,Lacosamide ,Seizures ,medicine ,Animals ,Pharmacology (medical) ,Valproic Acid ,CYP3A4 ,Behavior, Animal ,Dose-Response Relationship, Drug ,Kindling ,medicine.disease ,electrophysiology ,zebrafish ,Propanamide ,In vitro ,3. Good health ,030104 developmental biology ,Anticonvulsant ,chemistry ,Ethosuximide ,Pentylenetetrazole ,Original Article ,Anticonvulsants ,Neurology (clinical) ,Kindling model ,030217 neurology & neurosurgery ,medicine.drug - Abstract
In our recent studies, we identified compound N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) as a broad-spectrum hybrid anticonvulsant which showed potent protection across the most important animal acute seizure models such as the maximal electroshock (MES) test, the subcutaneous pentylenetetrazole (s.c. PTZ) test, and the 6-Hz (32 mA) test in mice. Therefore, AS-1 may be recognized as a candidate for new anticonvulsant effective in different types of human epilepsy with a favorable safety margin profile determined in the rotarod test in mice. In the aim of further pharmacological evaluation of AS-1, in the current study, we examined its activity in the 6-Hz (44 mA) test, which is known as the model of drug-resistant epilepsy. Furthermore, we determined also the antiseizure activity in the kindling model of epilepsy induced by repeated injection of pentylenetetrazole (PTZ) in mice. As a result, AS-1 revealed relatively potent protection in the 6-Hz (44 mA) test, as well as delayed the progression of kindling induced by repeated injection of PTZ in mice at doses of 15 mg/kg, 30 mg/kg, and 60 mg/kg. Importantly, the isobolographic analysis showed that a combination of AS-1 and valproic acid (VPA) at the fixed ratio of 1:1 displayed a supra-additive (synergistic) interaction against PTZ-induced seizures in mice. Thus, AS-1 may be potentially used in an add-on therapy with VPA. Moreover, incubation of zebrafish larvae with AS-1 substantially decreased the number, cumulative but not the mean duration of epileptiform-like events in electroencephalographic assay. Finally, the in vitro ADME-Tox studies revealed that AS-1 is characterized by a very good permeability in the parallel artificial membrane permeability assay test, excellent metabolic stability on human liver microsomes (HLMs), no significant influence on CYP3A4/CYP2D6 activity, and moderate inhibition of CYP2C9 in a concentration of 10 μM, as well as no hepatotoxic properties in HepG2 cells (concentration of 10 μM). Electronic supplementary material The online version of this article (10.1007/s13311-019-00773-w) contains supplementary material, which is available to authorized users.
- Published
- 2019
8. Zebrafish Larvae Carrying a Splice Variant Mutation in cacna1d: A New Model for Schizophrenia-Like Behaviours?
- Author
-
Linus De Witte, Kinga Gawel, Nancy Saana Banono, and Camila V. Esguerra
- Subjects
0301 basic medicine ,Psychosis ,Heterozygote ,Reflex, Startle ,Time Factors ,Calcium Channels, L-Type ,Genotype ,Neuroscience (miscellaneous) ,Context (language use) ,Motor Activity ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Neurobehaviour ,medicine ,Animals ,Zebrafish ,Alleles ,Genetics ,Thigmotaxis ,Splice site mutation ,biology ,Behavior, Animal ,Prepulse Inhibition ,Wild type ,Heterozygote advantage ,Electroencephalography ,Darkness ,Zebrafish Proteins ,medicine.disease ,biology.organism_classification ,Disease Models, Animal ,CACNA1D ,030104 developmental biology ,Neurology ,Larva ,Mutation ,Schizophrenia ,RNA Splice Sites ,Haploinsufficiency ,030217 neurology & neurosurgery ,Neuropsychiatric disorders - Abstract
Persons with certain single nucleotide polymorphisms (SNPs) in theCACNA1Dgene (encoding voltage-gated calcium channel subunit alpha 1-D) have increased risk of developing neuropsychiatric disorders such as bipolar, schizophrenia and autism. The molecular consequences of SNPs on gene expression and protein function are not well understood. Thus, the use of animal models to determine genotype-phenotype correlations is critical to understanding disease pathogenesis. Here, we describe the behavioural changes in larval zebrafish carrying an essential splice site mutation (sa17298) incacna1da. Heterozygous mutation resulted in 50% reduction of splice variants 201 and 202 (haploinsufficiency), while homozygosity increased transcript levels of variant 201 above wild type (WT; gain-of-function, GOF). Due to low homozygote viability, we focused primarily on performing the phenotypic analysis on heterozygotes. Indeed,cacna1dasa17298/WTlarvae displayed hyperlocomotion—a behaviour characterised in zebrafish as a surrogate phenotype for epilepsy, anxiety or psychosis-like behaviour. Follow-up tests ruled out anxiety or seizures, however, as neither thigmotaxis defects nor epileptiform-like discharges in larval brains were observed. We therefore focused on testing for potential “psychosis-like” behaviour by assayingcacna1dasa17298/WTlarval locomotor activity under constant light, during light-dark transition and in startle response to dark flashes. Furthermore, exposure of larvae to the antipsychotics, risperidone and haloperidol reversedcacna1da-induced hyperactivity to WT levels while valproate decreased but did not reverse hyperactivity. Together, these findings demonstrate thatcacna1dahaploinsufficiency induces behaviours in larval zebrafish analogous to those observed in rodent models of psychosis. Future studies on homozygous mutants will determine howcacna1dGOF alters behaviour in this context.
- Published
- 2020
9. The Influence of Palmatine Isolated from
- Author
-
Kinga, Gawel, Wirginia, Kukula-Koch, Dorota, Nieoczym, Katarzyna, Stepnik, Wietske van der, Ent, Nancy Saana, Banono, Dominik, Tarabasz, Waldemar A, Turski, and Camila V, Esguerra
- Subjects
Berberis ,Behavior, Animal ,Berberine ,Plant Extracts ,pentylenetetrazole ,Brain-Derived Neurotrophic Factor ,Berberine Alkaloids ,Berberis sibirica radix ,Quantitative Structure-Activity Relationship ,Electroencephalography ,complex mixtures ,Article ,Blood-Brain Barrier ,Seizures ,Larva ,palmatine ,Animals ,anticonvulsant activity ,EEG ,locomotor activity ,Proto-Oncogene Proteins c-fos ,isolation ,Locomotion ,Zebrafish - Abstract
Palmatine (PALM) and berberine (BERB) are widely identified isoquinoline alkaloids among the representatives of the Berberidaceae botanical family. The antiseizure activity of BERB was shown previously in experimental epilepsy models. We assessed the effect of PALM in a pentylenetetrazole (PTZ)-induced seizure assay in zebrafish, with BERB as an active reference compound. Both alkaloids were isolated from the methanolic root extract of Berberis sibirica by counter-current chromatography, and their ability to cross the blood–brain barrier was determined via quantitative structure–activity relationship assay. PALM exerted antiseizure activity, as confirmed by electroencephalographic analysis, and decreased c-fos and bdnf levels in PTZ-treated larvae. In a behavioral assay, PALM dose-dependently decreased PTZ-induced hyperlocomotion. The combination of PALM and BERB in ED16 doses revealed hyperadditive activity towards PTZ-induced hyperlocomotion. Notably, we have indicated that both alkaloids may exert their anticonvulsant activity through different mechanisms of action. Additionally, the combination of both alkaloids in a 1:2.17 ratio (PALM: BERB) mimicked the activity of the pure extract, which indicates that these two active compounds are responsible for its anticonvulsive activity. In conclusion, our study reveals for the first time the anticonvulsant activity of PALM and suggests the combination of PALM and BERB may have higher therapeutic value than separate usage of these compounds.
- Published
- 2020
10. Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene
- Author
-
Wietske van der Ent, Camila V. Esguerra, Waldemar A. Turski, Karolina Joanna Kirstein-Smardzewska, Anne Simonsen, Benan John Mathai, and Kinga Gawel
- Subjects
0301 basic medicine ,Morpholino ,Neuroscience (miscellaneous) ,Danio ,Context (language use) ,In situ hybridization ,Lamotrigine ,Motor Activity ,Article ,Touch response ,Morpholinos ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,medicine ,Antiseizure drugs ,Animals ,Humans ,Zebrafish ,Gene knockdown ,Epilepsy ,biology ,Behavior, Animal ,CACNA1A gene ,fungi ,Brain ,Gene Expression Regulation, Developmental ,Electroencephalography ,Zebrafish Proteins ,biology.organism_classification ,Loss of function ,3. Good health ,Cell biology ,030104 developmental biology ,Ethosuximide ,Phenotype ,Neurology ,Touch ,Gene Knockdown Techniques ,Larva ,Calcium Channels ,030217 neurology & neurosurgery ,medicine.drug - Abstract
TheCACNA1Agene encodes the pore-forming α1 subunit of voltage-gated P/Q type Ca2+channels (Cav2.1). Mutations in this gene, among others, have been described in patients and rodents suffering from absence seizures and episodic ataxia type 2 with/without concomitant seizures. In this study, we aimed for the first time to assess phenotypic and behavioral alterations in larval zebrafish with partialcacna1aaknockdown, placing special emphasis on changes in epileptiform-like electrographic discharges in larval brains. Whole-mount in situ hybridization analysis revealed expression ofcacna1aain the optic tectum and medulla oblongata of larval zebrafish at 4 and 5 days post-fertilization. Next, microinjection of two antisense morpholino oligomers (individually or in combination) targeting all splice variants ofcacna1aainto fertilized zebrafish eggs resulted in dose-dependent mortality and decreased or absent touch response. Over 90% knockdown ofcacna1aaon protein level induced epileptiform-like discharges in the optic tectum of larval zebrafish brains. Incubation of morphants with antiseizure drugs (sodium valproate, ethosuximide, lamotrigine, topiramate) significantly decreased the number and, in some cases, cumulative duration of epileptiform-like discharges. In this context, sodium valproate seemed to be the least effective. Carbamazepine did not affect the number and duration of epileptiform-like discharges. Altogether, our data indicate thatcacna1aaloss-of-function zebrafish may be considered a new model of absence epilepsy and may prove useful both for the investigation ofCacna1a-mediated epileptogenesis and for in vivo drug screening.
- Published
- 2020
11. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands
- Author
-
Sylwia Talarek, K.K. Wojtanowski, Malgorzata Jenda-Wojtanowska, Kinga Gawel, Ewa Gibula-Bruzda, L. Komsta, Marta Marszalek-Grabska, Joanna Filarowska, Jolanta Kotlinska, and Ewa Kędzierska
- Subjects
Male ,Tail ,0301 basic medicine ,Agonist ,Pyridines ,Pyridones ,medicine.drug_class ,Experimental and Cognitive Psychology ,Pharmacology ,Receptors, Metabotropic Glutamate ,Receptors, N-Methyl-D-Aspartate ,Nociceptive Pain ,Bridged Bicyclo Compounds ,Mice ,Random Allocation ,03 medical and health sciences ,Behavioral Neuroscience ,chemistry.chemical_compound ,0302 clinical medicine ,Allosteric Regulation ,AMN082 ,Excitatory Amino Acid Agonists ,medicine ,Animals ,Benzhydryl Compounds ,Analgesics ,Dose-Response Relationship, Drug ,Morphine ,Metabotropic glutamate receptor 7 ,Glutamate receptor ,Drug Tolerance ,Thiazoles ,030104 developmental biology ,MTEP ,chemistry ,Metabotropic glutamate receptor ,NMDA receptor ,Dizocilpine Maleate ,Excitatory Amino Acid Antagonists ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Preclinical data indicated that the metabotropic glutamate receptors 5 (mGlu5) and glutamate receptors 2/3 (mGlu2/3) are involved in modulating morphine antinociception. However, little is known about the role of metabotropic glutamate receptors 7 (mGlu7) in this phenomenon. We compared the effects of AMN082 (0.1, 1 or 5mg/kg, ip), a selective mGlu7 allosteric agonist, LY354740 (0.1, 1 or 5mg/kg, ip), an mGlu2/3 agonist and MTEP (0.1, 1 or 5mg/kg, ip), a selective mGlu5 antagonist, on the acute antinociceptive effect of morphine (5mg/kg, sc) and also on the development and expression of tolerance to morphine analgesia in the tail-immersion test in mice. To determine the role of mGlu7 in morphine tolerance, and the association of the mGlu7 effect with the N-methyl-d-aspartate (NMDA) receptors regulation, we used MMPIP (10mg/kg, ip), a selective mGlu7 antagonist and MK-801, a NMDA antagonist. Herein, the acute administration of AMN082, MTEP or LY354740 alone failed to evoked antinociception, and did not affect morphine (5mg/kg, sc) antinociception. However, these ligands inhibited the development of morphine tolerance, and we indicated that MMPIP reversed the inhibitory effect of AMN082. When given together, the non-effective doses of AMN082 and MK-801 did not alter the tolerance to morphine. Thus, mGlu7, similarly to mGlu2/3 and mGlu5, are involved in the development of tolerance to the antinociceptive effects of morphine, but not in the acute morphine antinociception. Furthermore, while mGlu7 are engaged in the development of morphine tolerance, no interaction exists between mGlu7 and NMDA receptors in this phenomenon.
- Published
- 2018
12. ADX-47273, a mGlu5 receptor positive allosteric modulator, attenuates deficits in cognitive flexibility induced by withdrawal from ‘binge-like’ ethanol exposure in rats
- Author
-
Wojciech Danysz, Sylwia Talarek, Ewa Gibula-Bruzda, Anna Bodzon-Kulakowska, Joanna Listos, Piotr Suder, Kinga Gawel, Jolanta Kotlinska, Marta Marszalek-Grabska, and Ewa Kędzierska
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Allosteric modulator ,Receptor, Metabotropic Glutamate 5 ,Spatial Learning ,Hippocampus ,Reversal Learning ,Motor Activity ,03 medical and health sciences ,Behavioral Neuroscience ,Cognition ,0302 clinical medicine ,Allosteric Regulation ,Piperidines ,ADX-47273 ,Internal medicine ,medicine ,Animals ,Rats, Wistar ,Oxadiazoles ,Ethanol ,Glutamate receptor ,Long-term potentiation ,Rats ,Substance Withdrawal Syndrome ,Barnes maze ,030104 developmental biology ,Metabotropic receptor ,Endocrinology ,NMDA receptor ,Psychology ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Repeated exposure to and withdrawal from ethanol induces deficits in spatial reversal learning. Data indicate that metabotropic glutamate 5 (mGlu5) receptors are implicated in synaptic plasticity and learning and memory. These receptors functionally interact with N-methyl- d -aspartate (NMDA) receptors, and activation of one type results in the activation of the other. We examined whether ( S )-(4-fluorophenyl)(3-(3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl)-piperidin-1-yl (ADX-47273), a positive allosteric modulator (PAM) of mGlu5 receptor, attenuates deficits in reversal learning induced by withdrawal (11-13 days) from ‘binge-like’ ethanol input (5.0 g/kg, i.g. for 5 days) in the Barnes maze (a spatial learning) task in rats. We additionally examined the effects of ADX-47273 on the expression of the NMDA receptors subunit, GluN2B, in the hippocampus and prefrontal cortex, on the 13th day of ethanol withdrawal. Herein, withdrawal from repeated ethanol administration impaired reversal learning, but not the probe trial. Moreover, ADX-47273 (30 mg/kg, i.p.) given prior to the first reversal learning trial for 3 days in the Barnes maze, significantly enhanced performance in the ethanol-treated group. The 13th day of ethanol abstinence decreased the expression of the GluN2 B subunit in the selected brain regions, but ADX-47273 administration increased it. In conclusion, positive allosteric modulation of mGlu5 receptors recovered spatial reversal learning impairment induced by withdrawal from ‘binge-like’ ethanol exposure. Such effect seems to be correlated with the mGlu5 receptors mediated potentiation of GluN2B-NMDA receptor mediated responses in the hippocampus and prefrontal cortex. Thus, our results emphasize the role of mGlu5 receptor PAM in the adaptive learning impaired by ethanol exposure.
- Published
- 2018
13. Impact of the metabotropic glutamate receptor7 (mGlu
- Author
-
Jolanta H, Kotlinska, Malgorzata, Lopatynska-Mazurek, Kinga, Gawel, Patrycja, Gabka, Malgorzata, Jenda-Wojtanowska, Marta, Kruk-Slomka, Marta, Marszalek-Grabska, Zofia, Danilczuk, Ewa, Kedzierska, Sylwia, Talarek, Joanna, Listos, and Ewa, Gibula-Tarlowska
- Subjects
Male ,Behavior, Animal ,Dose-Response Relationship, Drug ,Fear ,Anxiety ,Receptors, Metabotropic Glutamate ,Rats ,Substance Withdrawal Syndrome ,Mice ,Allosteric Regulation ,Memory ,Animals ,Benzhydryl Compounds ,Memory Consolidation - Abstract
The present study was conducted to evaluate the influence of AMN082, the metabotropic glutamate receptor subtype 7 (mGlu
- Published
- 2019
14. A critical review of zebrafish schizophrenia models: Time for validation?
- Author
-
Kinga Gawel, Camila V. Esguerra, Agnieszka Michalak, and Nancy Saana Banono
- Subjects
Cognitive Neuroscience ,Population ,Disease ,03 medical and health sciences ,Behavioral Neuroscience ,Broad spectrum ,0302 clinical medicine ,Medicine ,Animals ,0501 psychology and cognitive sciences ,050102 behavioral science & comparative psychology ,education ,Zebrafish ,High potential ,education.field_of_study ,biology ,business.industry ,05 social sciences ,biology.organism_classification ,Precision medicine ,medicine.disease ,Disease Models, Animal ,Neuropsychology and Physiological Psychology ,Schizophrenia ,business ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Schizophrenia is a mental disorder that affects 1% of the population worldwide and is manifested as a broad spectrum of symptoms, from hallucinations to memory impairment. It is believed that genetic and/or environmental factors may contribute to the occurrence of this disease. Recently, the zebrafish has emerged as a valuable and attractive model for various neurological disorders including schizophrenia. In this review, we describe current pharmacological models of schizophrenia with special emphasis on providing insights into the pros and cons of using zebrafish as a behavioural model of this disease. Moreover, we highlight the advantages and utility of using zebrafish for elucidating the genetic mechanisms underlying this psychiatric disorder. We believe that the zebrafish has high potential also in the area of precision medicine and may complement the development of therapeutics, especially for pharmacoresistant patients.
- Published
- 2019
15. Anticonvulsant Activity of Pterostilbene in Zebrafish and Mouse Acute Seizure Tests
- Author
-
Kinga Gawel, Piotr Wlaź, Camila V. Esguerra, Katarzyna Socała, Elżbieta Wyska, and Dorota Nieoczym
- Subjects
0301 basic medicine ,Pterostilbene ,medicine.medical_treatment ,Central nervous system ,Pharmacology ,Biochemistry ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,Epilepsy ,Mice ,0302 clinical medicine ,Seizures ,Stilbenes ,medicine ,Animals ,Muscle Strength ,Side effects ,Zebrafish ,Original Paper ,Electroshock ,Seizure threshold ,Dose-Response Relationship, Drug ,business.industry ,Depression ,General Medicine ,medicine.disease ,Antidepressive Agents ,Motor coordination ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Anticonvulsant ,chemistry ,Antidepressant ,Pentylenetetrazole ,Anticonvulsants ,business ,030217 neurology & neurosurgery ,Behavioural despair test - Abstract
Pterostilbene (PTE), a natural dimethylated analog of resveratrol, possesses numerous health-beneficial properties. The ability of PTE to cross the blood–brain barrier raised the possibility that this compound may modulate central nervous system functions, including seizure activity. The aim of our study was to investigate the activity of PTE in the larval zebrafish pentylenetetrazole (PTZ) seizure assay and three acute seizure tests in mice, i.e., in the maximal electroshock seizure threshold (MEST), 6 Hz-induced psychomotor seizure threshold and intravenous (iv) PTZ tests. Additionally, potential antidepressant activity of PTE was estimated in the forced swim test in mice. The chimney test was used to determine the influence of PTE on motor coordination in mice, while its influence on neuromuscular strength was assessed in the grip strength test in mice. Locomotor activity was determined to verify the results from the forced swim test. PTE revealed an evident anticonvulsant effect both in zebrafish larvae (10 µM; 2 h-incubation) and mice (at doses of 100 and 200 mg/kg, intraperitoneally) but it did not exhibit antidepressant potential in the forced swim test. Furthermore, it did not cause any statistically significant changes in motor coordination, neuromuscular strength and locomotor activity in mice. In conclusion, our present findings demonstrate for the first time the anticonvulsant potential of PTE. The aforementioned results suggest that it might be employed in epilepsy treatment, however, further precise studies are required to verify its activity in other experimental seizure and epilepsy models and its precise mechanism of action should be determined.
- Published
- 2019
16. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats
- Author
-
Marta Marszalek-Grabska, Kinga Gawel, Krzysztof Labuz, Ewa Gibula-Bruzda, Joanna Filarowska, Małgorzata Jenda, Jolanta Kotlinska, and Jerzy Silberring
- Subjects
Male ,0301 basic medicine ,Time Factors ,Synaptic cleft ,medicine.drug_class ,Rivastigmine ,Motor Activity ,Pharmacology ,Barnes maze ,03 medical and health sciences ,Cognition ,Spatial memory ,0302 clinical medicine ,Piperidines ,Reaction Time ,medicine ,Animals ,Memory impairment ,Donepezil ,Rats, Wistar ,Maze Learning ,Nootropic Agents ,Cholinesterase ,Memory Disorders ,Behavior, Animal ,Dose-Response Relationship, Drug ,Ethanol ,biology ,General Medicine ,Disease Models, Animal ,030104 developmental biology ,Acetylcholinesterase inhibitor ,Rotarod Performance Test ,Anesthesia ,Indans ,biology.protein ,Cholinergic ,Original Article ,Cholinesterase Inhibitors ,Cognition Disorders ,Psychology ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Central cholinergic dysfunction contributes to acute spatial memory deficits produced by ethanol administration. Donepezil and rivastigmine elevate acetylcholine levels in the synaptic cleft through the inhibition of cholinesterases—enzymes involved in acetylcholine degradation. The aim of our study was to reveal whether donepezil (acetylcholinesterase inhibitor) and rivastigmine (also butyrylcholinesterase inhibitor) attenuate spatial memory impairment as induced by acute ethanol administration in the Barnes maze task (primary latency and number of errors in finding the escape box) in rats. Additionally, we compared the influence of these drugs on ethanol-disturbed memory. In the first experiment, the dose of ethanol (1.75 g/kg, i.p.) was selected that impaired spatial memory, but did not induce motor impairment. Next, we studied the influence of donepezil (1 and 3 mg/kg, i.p.), as well as rivastigmine (0.5 and 1 mg/kg, i.p.), given either before the probe trial or the reversal learning on ethanol-induced memory impairment. Our study demonstrated that these drugs, when given before the probe trial, were equally effective in attenuating ethanol-induced impairment in both test situations, whereas rivastigmine, at both doses (0.5 and 1 mg/kg, i.p.), and donepezil only at a higher dose (3 mg/kg, i.p.) given prior the reversal learning, attenuated the ethanol-induced impairment in cognitive flexibility. Thus, rivastigmine appears to exert more beneficial effect than donepezil in reversing ethanol-induced cognitive impairments—probably due to its wider spectrum of activity. In conclusion, the ethanol-induced spatial memory impairment may be attenuated by pharmacological manipulation of central cholinergic neurotransmission.
- Published
- 2016
17. Acquisition and reinstatement of ethanol-induced conditioned place preference in rats: Effects of the cholinesterase inhibitors donepezil and rivastigmine
- Author
-
Jerzy Silberring, Kinga Gawel, Ewa Gibula-Bruzda, Krzysztof Labuz, Marta Marszalek-Grabska, Małgorzata Jenda, and Jolanta Kotlinska
- Subjects
Male ,0301 basic medicine ,Scopolamine ,Rivastigmine ,Muscarinic Antagonists ,Nicotinic Antagonists ,Mecamylamine ,Receptors, Nicotinic ,Pharmacology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Piperidines ,Conditioning, Psychological ,Muscarinic acetylcholine receptor ,medicine ,Animals ,Donepezil ,Pharmacology (medical) ,Rats, Wistar ,Cholinesterase ,Ethanol ,biology ,Acetylcholinesterase ,Conditioned place preference ,Rats ,Psychiatry and Mental health ,Nicotinic acetylcholine receptor ,030104 developmental biology ,Nicotinic agonist ,chemistry ,Indans ,biology.protein ,Cholinesterase Inhibitors ,Reinforcement, Psychology ,030217 neurology & neurosurgery ,medicine.drug - Abstract
The present study examined the influence of the cholinesterase inhibitors donepezil (a selective inhibitor of acetylcholinesterase) and rivastigmine (also an inhibitor of butyrylcholinesterase) on the acquisition and reinstatement of ethanol-induced conditioned place preference (CPP) in rats. Before the CPP procedure, animals received a single injection of ethanol (0.5 g/kg, 10% w/v, intraperitoneally [i.p.]) for 15 days. The ethanol-induced CPP (biased method) was developed by four injections of ethanol (0.5 g/kg, 10% w/v, i.p.) every second day. Control rats received saline instead of ethanol. Donepezil (0.5, 1 or 3 mg/kg, i.p.) or rivastigmine (0.03, 0.5 or 1 mg/kg, i.p.) were administered before ethanol during conditioning or before the reinstatement of ethanol-induced CPP. The cholinesterase inhibitors were equally effective in increasing (dose dependently) the acquisition of ethanol-induced CPP. Furthermore, priming injections of both inhibitors reinstated (cross-reinstatement) the ethanol-induced CPP with similar efficacy. These effects of both cholinesterase inhibitors were reversed by mecamylamine (3 mg/kg, i.p.), a nicotinic acetylcholine receptor antagonist, but not by scopolamine (0.5 mg/kg, i.p.), a muscarinic acetylcholine receptor antagonist. Thus, our results show that the cholinergic system is involved in the reinforcing properties of ethanol, and nicotinic acetylcholine receptors play an important role in the relapse to ethanol-seeking behaviour.
- Published
- 2016
18. Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Maintenance Association between Environmental Cues and Rewarding Properties of Ethanol in Rats
- Author
-
Joanna Listos, Kinga Gawel, Marta Marszalek-Grabska, Jolanta Kotlinska, Ewa Gibula-Tarlowska, and Dariusz Matosiuk
- Subjects
Male ,0301 basic medicine ,Allosteric modulator ,medicine.drug_class ,Receptor, Metabotropic Glutamate 5 ,lcsh:QR1-502 ,Pharmacology ,Biochemistry ,Article ,lcsh:Microbiology ,memory ,03 medical and health sciences ,0302 clinical medicine ,Allosteric Regulation ,medicine ,Animals ,Rats, Wistar ,Molecular Biology ,reward ,Metabotropic glutamate receptor 5 ,Chemistry ,Glutamate receptor ,Receptor antagonist ,conditioned place preference ,Conditioned place preference ,Rats ,Alcoholism ,030104 developmental biology ,MTEP ,Metabotropic receptor ,mGlu5 receptor ,positive allosteric modulator ,Benzamides ,Pyrazoles ,NMDA receptor ,ethanol ,Cues ,VU-29 ,030217 neurology & neurosurgery - Abstract
Metabotropic glutamate subtype 5 (mGlu5) receptors are implicated in various forms of synaptic plasticity, including drugs of abuse. In drug-addicted individuals, associative memories can drive relapse to drug use. The present study investigated the potential of the mGlu5 receptor positive allosteric modulator (PAM), VU-29 (30 mg/kg, i.p.), to inhibit the maintenance of a learned association between ethanol and environmental context by using conditioned place preference (CPP) in rats. The ethanol-CPP was established by the administration of ethanol (1.0 g/kg, i.p. ×, 10 days) using an unbiased procedure. Following ethanol conditioning, VU-29 was administered at various post-conditioning times (ethanol free state at the home cage) to ascertain if there was a temporal window during which VU-29 would be effective. Our experiments indicated that VU-29 did not affect the expression of ethanol-induced CPP when it was given over two post-conditioning days. However, the expression of ethanol-CPP was inhibited by 10-day home cage administration of VU-29, but not by first 2-day or last 2-day injection of VU-29 during the 10-day period. These findings reveal that VU-29 can inhibit the maintenance of ethanol-induced CPP, and that treatment duration contributes to this effect of VU-29. Furthermore, VU-29 effect was reversed by pretreatment with either MTEP (the mGlu5 receptor antagonist), or MK-801 (the N-methyl-D-aspartate-NMDA receptor antagonist). Thus, the inhibitory effect of VU-29 is dependent on the functional interaction between mGlu5 and NMDA receptors. Because a reduction in ethanol-associated cues can reduce relapse, mGlu5 receptor PAM would be useful for therapy of alcoholism. Future research is required to confirm the current findings.
- Published
- 2020
19. Kynurenic acid as the neglected ingredient of commercial baby formulas
- Author
-
Ewa Tomaszewska, Iwona Dębińska, Waldemar A. Turski, Michal Raban, Jerzy Bednarski, Katarzyna Smolińska, Tomasz Kocki, Monika Turska, Paweł Milart, Piotr Paluszkiewicz, Katarzyna Walczak, Kinga Gawel, and Piotr Dobrowolski
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Offspring ,Breastfeeding ,lcsh:Medicine ,Context (language use) ,Breast milk ,Kynurenic Acid ,Weight Gain ,Article ,Jejunum ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Kynurenic acid ,Internal medicine ,medicine ,Animals ,Humans ,Obesity ,Rats, Wistar ,lcsh:Science ,Infant Nutritional Physiological Phenomena ,Multidisciplinary ,Milk, Human ,business.industry ,lcsh:R ,Infant, Newborn ,Infant ,medicine.disease ,Infant Formula ,Rats ,Gastrointestinal Tract ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,Breast Feeding ,chemistry ,Dietary Supplements ,lcsh:Q ,Female ,medicine.symptom ,business ,Weight gain ,030217 neurology & neurosurgery ,Metabolic Networks and Pathways - Abstract
The global increase in resorting to artificial nutritional formulas replacing breastfeeding has been identified among the complex causes of the obesity epidemic in infants and children. One of the factors recently recognized to influence metabolism and weight gain is kynurenic acid (KYNA), an agonist of G protein-coupled receptor (GPR35). Therefore the aim of the study was to determine the concentration of KYNA in artificial nutritional formulas in comparison with its level in human breast milk and to evaluate developmental changes in rats exposed to KYNA enriched diet during the time of breastfeeding. KYNA levels were measured in milk samples from 25 heathy breast-feeding women during the first six months after labor and were compared with 21 time-adjusted nutritional formulas. Animal experiments were performed on male Wistar rats. KYNA was administered in drinking water. The content of KYNA in human milk increases more than 13 times during the time of breastfeeding while its level is significantly lower in artificial formulas. KYNA was detected in breast milk of rats and it was found that the supplementation of rat maternal diet with KYNA in drinking water results in its increase in maternal milk. By means of the immunoblotting technique, GPR35 was evidenced in the mucosa of the jejunum of 1-day-old rats and distinct morphological changes in the jejunum of 21-day-old rats fed by mothers exposed to water supplemented with KYNA were found. A significant reduction of body weight gain of rats postnatally exposed to KYNA supplementation without changes in total body surface and bone mineral density was observed. The rat offspring fed with breast milk with artificially enhanced KYNA content demonstrated a lower mass gain during the first 21 days of life, which indicates that KYNA may act as an anti-obesogen. Further studies are, therefore, warranted to investigate the mechanisms regulating KYNA secretion via breast milk, as well as the influence of breast milk KYNA on mass gain. In the context of lifelong obesity observed worldwide in children fed artificially, our results imply that insufficient amount of KYNA in baby formulas could be considered as one of the factors associated with increased mass gain.
- Published
- 2018
20. Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration
- Author
-
Ewa Gibula, Kinga Gawel, Marta Marszalek-Grabska, Joanna Filarowska, and Jolanta Kotlinska
- Subjects
0301 basic medicine ,Computer science ,Pharmacology toxicology ,Rodentia ,Review ,Rodents ,Barnes maze ,Task (project management) ,03 medical and health sciences ,Apparatus ,0302 clinical medicine ,Spatial memory ,Memory ,Procedure ,Protocol ,Animals ,Humans ,Maze Learning ,Pharmacology ,Protocol (science) ,Memory Disorders ,Behavior, Animal ,Cognitive flexibility ,General Medicine ,Disease Models, Animal ,030104 developmental biology ,Spatial learning ,030217 neurology & neurosurgery ,Cognitive psychology - Abstract
Among the methods valuable for assessing spatial learning and memory impairments in rodents, the Barnes maze (BM) task deserves special attention. It is based on the assumption that the animal placed into the aversive environment should learn and remember the location of an escape box located below the surface of the platform. Different phases of the task allow to measure spatial learning, memory retrieval, and cognitive flexibility. Herein, we summarize current knowledge about the BM procedure, its variations and critical parameters measured in the task. We highlight confounding factors which should be taken into account when conducting BM task, discussing briefly its advantages and disadvantages. We then propose an extended version of the BM protocol which allows to measure different aspects of spatial learning and memory in rodents. We believe that this review will help to standardize the BM methodology across the laboratories and eventually make the results comparable.
- Published
- 2018
21. The influence of the new enkephalin derivative, cyclo[Nε,Nβ-carbonyl-d-Lys2,Dap5] enkephalinamide (cUENK6), on reinstatement of ethanol-induced conditioned place preference in rats
- Author
-
Kinga Gawel, Jan Izdebski, Ewa Gibula-Bruzda, Jolanta Kotlinska, Marta Marszalek-Grabska, and Ewa Witkowska
- Subjects
Male ,Agonist ,Enkephalin ,medicine.drug_class ,Narcotic Antagonists ,Experimental and Cognitive Psychology ,Motor Activity ,Pharmacology ,Behavioral Neuroscience ,Naltrindole ,Opioid receptor ,polycyclic compounds ,medicine ,Animals ,Rats, Wistar ,Analysis of Variance ,Neurotransmitter Agents ,Dose-Response Relationship, Drug ,Ethanol ,Chemistry ,Antagonist ,Central Nervous System Depressants ,Enkephalins ,Extinction (psychology) ,Conditioned place preference ,Rats ,nervous system ,Conditioning, Operant ,Norbinaltorphimine ,Reinforcement, Psychology ,medicine.drug - Abstract
The aim of the present study was to determine whether a new cyclic analog of enkephalin, cyclo[N(ε),N(β)-carbonyl-d-Lys(2),Dap(5)] enkephalinamide (cUENK6), a preferential μ-(MORs), and, to a lower extent, a δ-opioid receptor (DORs) agonist in vitro, could reinstate ethanol-induced conditioned place preference (CPP). In our work, male Wistar rats were first conditioned either with ethanol (10% w/v, 0.5g/kg, intraperitoneally (i.p.)) or 0.9% NaCl in a biased CPP procedure. The intracerebroventricular (i.c.v.) administration of DORs antagonist (naltrindole, 2.5 and 5nmol) or MORs antagonist (β-funaltrexamine, 5 and 10nmol), but not the κ opioid receptor (KORs) antagonist (norbinaltorphimine, 5 and 10nmol) was then administered and inhibited the expression of ethanol-induced CPP. After the extinction session, i.c.v. administration of cUENK6 at the dose of 0.125, 0.25 and 0.5nmol occurred, and was found to reinstate the ethanol-induced CPP similar to that of the priming injection of ethanol. However, the reinstated effect of cUENK6 (0.25nmol) was strongly abolished by administration of naltrindole and, to lesser extent, by β-funaltrexamine. Furthermore, the preferential MORs agonist-morphine (13nmol, i.c.v.) and the DORs agonist-[Leu(5)]-enkephalin (2.7 and 5.4nmol, i.c.v.) also reinstated the ethanol-induced CPP. cUENK6 given alone at the dose of 0.25nmol before the testing phase had no effect in animals that received 0.9% NaCl during the conditioning phase and also did not influence their locomotor activity. These data suggest that the effects of cUENK6 did not have an impact on the results obtained in the reinstatement procedure of CPP. Overall, the data support the idea that both MORs and DORs are normally involved in the expression and reinstatement of ethanol conditioned seeking behavior - as indexed by CPP in rats.
- Published
- 2015
22. Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Impairment of Novel Object Recognition Induced by Acute Ethanol and Ethanol Withdrawal in Rats
- Author
-
Marta Marszalek-Grabska, Piotr Suder, Ewa Gibula-Bruzda, Joanna Filarowska, Anna Bodzon-Kulakowska, Jolanta Kotlinska, Wojciech Danysz, Joanna Listos, and Kinga Gawel
- Subjects
0301 basic medicine ,Male ,Allosteric modulator ,Receptor, Metabotropic Glutamate 5 ,Novel object recognition ,Hippocampus ,Striatum ,Pharmacology ,Toxicology ,Statistics, Nonparametric ,03 medical and health sciences ,Glutamatergic ,0302 clinical medicine ,Allosteric Regulation ,Animals ,Rats, Wistar ,Prefrontal cortex ,Maze Learning ,Memory Disorders ,Dose-Response Relationship, Drug ,Ethanol ,Chemistry ,Metabotropic glutamate receptor 5 ,General Neuroscience ,Glutamate receptor ,Brain ,Central Nervous System Depressants ,Recognition, Psychology ,Rats ,Substance Withdrawal Syndrome ,Disease Models, Animal ,030104 developmental biology ,Metabotropic receptor ,mGlu5 receptor ,Benzamides ,Pyrazoles ,Original Article ,VU-29 ,030217 neurology & neurosurgery ,Locomotion - Abstract
Glutamate is essential for learning and memory processes, and acute and chronic exposures to ethanol (or protracted abstinence) alter glutamatergic transmission. In the current study, we investigated the effects of VU-29, positive allosteric modulator of metabotropic glutamate 5 (mGlu5) receptor, on the acute ethanol- and ethanol withdrawal-induced impairment of novel object recognition (NOR) task in rats. The influence of VU-29 (30 mg/kg) on memory retrieval was measured (a) at 4-h delay after acute ethanol administration, as well as (b) after acute withdrawal (24 and 48 h) of repeated (2.0 g/kg, once daily for 7 days) ethanol administration. Additionally, the effects of VU-29 on expression of mGlu5 and mGlu2 receptor proteins in the hippocampus, prefrontal cortex, and striatum were determined 48 h after ethanol withdrawal. Our results indicated that VU-29, given before acute ethanol administration, prevented the ethanol-induced impairments in spatial memory retrieval. Furthermore, VU-29 given before the testing session on the first day of abstinence facilitated NOR performance in ethanol-withdrawn rats at 4- and 24-h delay after administration. Our ELISA results show that VU-29 normalized ethanol withdrawal induced increase in expression of mGlu5 receptor protein in the hippocampus, prefrontal cortex, and striatum, as well as expression of mGlu2 receptor protein in the hippocampus. Thus, results from our study indicate that positive modulation of mGlu5 receptor prevented and reversed ethanol-induced memory impairment. Moreover, mGlu5 (hippocampus, prefrontal cortex, and striatum) and mGlu2 (hippocampus) receptors play an important role in the ethanol-induced recognition memory impairment induced by ethanol withdrawal.
- Published
- 2017
23. The new kisspeptin derivative - kissorphin (KSO) - attenuates acute hyperlocomotion and sensitization induced by ethanol and morphine in mice
- Author
-
Ewa Gibula-Bruzda, Roza Trzcinska, Jolanta Kotlinska, Marta Marszalek-Grabska, Kinga Gawel, and Jerzy Silberring
- Subjects
Male ,Health (social science) ,Pharmacology ,Toxicology ,Biochemistry ,03 medical and health sciences ,Behavioral Neuroscience ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,medicine ,Animals ,Neuropeptide FF ,Sensitization ,Psychomotor Agitation ,Kisspeptins ,Ethanol ,Dose-Response Relationship, Drug ,Morphine ,Antagonist ,Biological activity ,General Medicine ,030227 psychiatry ,Motor coordination ,medicine.anatomical_structure ,Neurology ,chemistry ,Opioid ,030217 neurology & neurosurgery ,Locomotion ,medicine.drug ,Akathisia, Drug-Induced - Abstract
Kissorphin (KSO) is a new peptide derived from kisspeptin-10. This peptide possesses neuropeptide FF (NPFF)-like biological activity in vitro ; NPFF, in many cases, inhibits opioid and ethanol effects in rodents. Therefore, the current study explored the influence of KSO on acute ethanol- and morphine-induced hyperactivity, and on the development and expression of locomotor sensitization induced by these drugs. In the present study, sensitization to locomotor effects was induced by repeated exposure to ethanol (2.4 g/kg, intraperitoneally [i.p.], 1 × 4 days) or morphine (10 mg/kg, subcutaneously [s.c.], 1 × 7 days). We found that KSO (1–10 nmol/300 μL, intravenously [i.v.]) did not have an impact on locomotor activity of naive mice. However, it reduced both acute ethanol- (10 nmol/300 μL) and morphine-induced hyperactivity (3 and 10 nmol/300 μL). Pretreatment of animals with KSO (10 nmol/300 μL), before every ethanol or morphine injection during development of sensitization or before the ethanol or morphine challenge, attenuated the development, as well as the expression of locomotor sensitization to both substances. Moreover, prior administration of the NPFF receptor antagonist RF9 (10 nmol/300 μL, i.v.) inhibited the ability of KSO (10 nmol/300 μL) to reduce the expression of ethanol and morphine sensitization. KSO given alone, at all used doses, did not influence the motor coordination measured via the rotarod test. The results from this study show that KSO effectively attenuated acute and repeated effects of ethanol and morphine. Thus, KSO possesses NPFF-like anti-opioid activity in these behavioral studies.
- Published
- 2016
24. Cholinergic activation affects the acute and chronic antinociceptive effects of morphine
- Author
-
Marta Marszalek-Grabska, Jolanta Kotlinska, Malgorzata Jenda-Wojtanowska, Kinga Gawel, Marcin Dziedzic, Ewa Gibula-Bruzda, and Jerzy Silberring
- Subjects
0301 basic medicine ,Male ,Time Factors ,Analgesic ,Pain ,Experimental and Cognitive Psychology ,Rivastigmine ,Pharmacology ,03 medical and health sciences ,Behavioral Neuroscience ,Mice ,0302 clinical medicine ,Piperidines ,Mecamylamine ,Medicine ,Animals ,Donepezil ,Hot plate test ,Cholinesterase ,Pain Measurement ,Analysis of Variance ,biology ,Dose-Response Relationship, Drug ,Morphine ,business.industry ,Drug Synergism ,Acetylcholine ,Analgesics, Opioid ,Disease Models, Animal ,030104 developmental biology ,Opioid ,Area Under Curve ,Indans ,biology.protein ,Cholinergic ,Cholinesterase Inhibitors ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Current studies indicate that the cholinergic and opioid systems interact to modulate pain. In the present work, we investigated the influence of the cholinesterase inhibitors, donepezil (0.5; 1 or 3mg/kg, i.p.) and rivastigmine (0.03; 0.5 or 1mg/kg, i.p.), on the acute antinociceptive effects of morphine (5mg/kg, i.p.) in the hot plate test in mice. Herein, both inhibitors were found to enhance and prolong the analgesic effects of morphine without affecting latencies themselves. In an extension of this work, we determined which cholinergic receptors subtype mediates the enhancement of analgesic effects of morphine, following inhibition of cholinesterases. In this part of the study, scopolamine (0.5mg/kg, i.p.), a muscarinic cholinergic receptors antagonist, but not mecamylamine (3mg/kg, i.p.), a nicotinic cholinergic receptors antagonist, reversed the enhancing effects of donepezil (3mg/kg, i.p.) and rivastigmine (1mg/kg, i.p.) on the morphine antinociception. Moreover, both cholinesterase inhibitors attenuated the development of tolerance to the antinociceptive effects of morphine. In contrast, acute administration of donepezil (3mg/kg, i.p.) or rivastigmine (1mg/kg, i.p.) on the day of expression of tolerance, had no effect on the already developed morphine tolerance. What is more, in both set of experiments, rivastigmine was slightly more potent than donepezil due to the broader inhibitory spectrum of this drug on acetylcholine degradation. Thus, our results suggest that the cholinesterase inhibitors, donepezil and rivastigmine, may be administered with morphine in order to enhance the latter's analgesic effects for the treatment of acute and chronic pain.
- Published
- 2016
25. Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats
- Author
-
Ewa Gibula-Bruzda, Kinga Gawel, Jolanta Kotlinska, Marta Marszalek-Grabska, and Małgorzata Jenda
- Subjects
0301 basic medicine ,Male ,Imipramine ,medicine.drug_class ,Amphetamine-Related Disorders ,Scopolamine ,Tricyclic antidepressant ,Muscarinic Antagonists ,Pharmacology ,Receptors, N-Methyl-D-Aspartate ,03 medical and health sciences ,0302 clinical medicine ,Memantine ,medicine ,Animals ,Rats, Wistar ,Amphetamine ,Molecular Biology ,Nootropic Agents ,Memory Disorders ,Dose-Response Relationship, Drug ,Depression ,General Neuroscience ,Antagonist ,Recognition, Psychology ,Receptor antagonist ,Antidepressive Agents ,Substance Withdrawal Syndrome ,Disease Models, Animal ,030104 developmental biology ,Anesthesia ,NMDA receptor ,Central Nervous System Stimulants ,Neurology (clinical) ,Dizocilpine Maleate ,Psychology ,Excitatory Amino Acid Antagonists ,030217 neurology & neurosurgery ,Developmental Biology ,medicine.drug ,Behavioural despair test - Abstract
Amphetamine (AMPH) induces deficits in cognition, and depressive-like behavior following withdrawal. The aim of the present study was to investigate whether pre-treatment with memantine (5mg/kg, i.p.), a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, attenuates memory impairment induced by withdrawal from a 1 day binge regimen of AMPH (2mg/kg, four times every 2h, i.p.), in the novel object recognition test in rats. Herein, the influence of scopolamine (0.1mg/kg), an antagonist of the muscarinic cholinergic receptors, and the impact of MK-801 (0.1mg/kg), an antagonist of the NMDA receptors, on the memantine effect, were ascertained. Furthermore, the impact of memantine (5; 10; 20mg/kg, i.p.) was measured on depression-like effects of abstinence, 14 days after the last AMPH treatment (2mg/kg×1×14 days), in the forced swim test. In this test, the efficacy of memantine was compared to that of tricyclic antidepressant imipramine (10; 20; 30mg/kg, i.p.). Our study indicated that withdrawal from a binge regimen of AMPH impaired recognition memory. This effect was attenuated by administration of memantine at both 72h and 7 days of withdrawal. Moreover, prior administration of scopolamine, but not MK-801, decreased the memantine-induced recognition memory improvement. In addition, memantine reversed the AMPH-induced depressive-like behavior in the forced swim test in rats. The antidepressant-like effects of memantine were stronger than those of imipramine. Our study indicates that memantine constitutes a useful approach towards preventing cognitive deficits induced by withdrawal from an AMPH binge regimen and by depressive-like behavior during AMPH abstinence.
- Published
- 2015
26. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice
- Author
-
L. Komsta, Kinga Gawel, Małgorzata Jenda, M. Marszalek, and Jolanta Kotlinska
- Subjects
Agonist ,Male ,medicine.drug_class ,Pyridones ,medicine.medical_treatment ,Pharmacology ,Receptors, Metabotropic Glutamate ,chemistry.chemical_compound ,Mice ,AMN082 ,Allosteric Regulation ,Cocaine ,medicine ,Animals ,Drug Interactions ,Benzhydryl Compounds ,Biological Psychiatry ,Sensitization ,Central Nervous System Sensitization ,Dose-Response Relationship, Drug ,Morphine ,business.industry ,Metabotropic glutamate receptor 7 ,Stimulant ,medicine.anatomical_structure ,chemistry ,Opioid ,Metabotropic glutamate receptor ,business ,Locomotion ,medicine.drug - Abstract
Previous studies have indicated that metabotropic glutamate receptors 7 (mGluR7s) are involved in drug addiction. However, the role of these receptors in drug-induced behavioral sensitization is unknown. The aim of the present study was to determine whether systemic injection of AMN082, a selective mGluR7 allosteric agonist, reduces the cocaine- and morphine-induced hyperactivity and the development and expression of locomotor sensitization, and also affects the reciprocal cross-sensitization to the stimulant effect of cocaine and morphine in mice. AMN082 (1.25-10.0 mg/kg, i.p.) did not have an impact on locomotion of naive mice and did not affect the acute cocaine- or morphine-induced hyperactivity, except the dose of 10 mg/kg that suppressed the locomotor effect of both drugs. Repeated exposure to cocaine or morphine (10 mg/kg, 5× every 3 days) gradually increased locomotion during induction of sensitization and after 4 (cocaine) or 7 day (morphine) withdrawal phase when challenged with cocaine (10 mg/kg, i.p.) or morphine (10 mg/kg, i.p.) on day 17 or 20, respectively. Pretreatment of animals with the lower doses of AMN082 (1.25-5.0 mg/kg, i.p.), 30 min before every cocaine or morphine injection during repeated drug administration or before cocaine or morphine challenge, dose-dependently attenuated the development, as well as the expression of cocaine or morphine locomotor sensitization. AMN082 also inhibited the reciprocal cross-sensitization between these drugs. Prior to administration of MMPIP (10 mg/kg, i.p.), a selective mGluR7 antagonist reversed the inhibitory effect of AMN082 on the development or expression of cocaine or morphine sensitization. These data indicate that AMN082 attenuated the development and expression of cocaine and morphine sensitization, and the reciprocal cross-sensitization via a mechanism that involves mGluR7s. Thus, AMN082 might have therapeutic implications not only in the treatment of cocaine or opioid addiction but also in the treatment of cocaine/opioid polydrug-abusers.
- Published
- 2014
27. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats
- Author
-
Małgorzata Jenda, Kinga Gawel, Jolanta Kotlinska, Jerzy Silberring, and Krzysztof Labuz
- Subjects
Male ,Narcotics ,Drug-Seeking Behavior ,Scopolamine ,Phenylcarbamates ,Rivastigmine ,Muscarinic Antagonists ,Nicotinic Antagonists ,Pharmacology ,Mecamylamine ,Motor Activity ,Behavioral Neuroscience ,chemistry.chemical_compound ,Piperidines ,Conditioning, Psychological ,medicine ,Animals ,Donepezil ,Rats, Wistar ,Butyrylcholinesterase ,Cholinesterase ,biology ,Morphine ,Chemistry ,Acetylcholinesterase ,Conditioned place preference ,Nicotinic agonist ,Space Perception ,Indans ,biology.protein ,Cholinesterase Inhibitors ,medicine.drug - Abstract
The influence of systemic administration of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference (CPP) was examined in rats. Additionally, this study aimed to compare the effects of donepezil, which selectively inhibits acetylcholinesterase, and rivastigmine, which inhibits both acetylcholinesterase and butyrylcholinesterase on morphine reward. Morphine-induced CPP (unbiased method) was induced by four injections of morphine (5 mg/kg, i.p.). Donepezil (0.5, 1, and 3 mg/kg, i.p.) or rivastigmine (0.03, 0.5, and 1 mg/kg, i.p.) were given 20 min before morphine during conditioning phase and 20 min before the expression or reinstatement of morphine-induced CPP. Our results indicated that both inhibitors of cholinesterase attenuated the acquisition and expression of morphine CPP. The results were more significant after rivastigmine due to a broader inhibitory spectrum of this drug. Moreover, donepezil (1 mg/kg) and rivastigmine (0.5 mg/kg) attenuated the morphine CPP reinstated by priming injection of 5mg/kg morphine. These properties of both cholinesterase inhibitors were reversed by mecamylamine (3 mg/kg, i.p.), a nicotinic acetylcholine receptor antagonist but not scopolamine (0.5 mg/kg, i.p.), a muscarinic acetylcholine receptor antagonist. All effects of cholinesterase inhibitors were observed at the doses that had no effects on locomotor activity of animals. Our results suggest beneficial role of cholinesterase inhibitors in reduction of morphine reward and morphine-induced seeking behavior. Finally, we found that the efficacy of cholinesterase inhibitors in attenuating reinstatement of morphine CPP provoked by priming injection may be due to stimulation of nicotinic acetylcholine receptors.
- Published
- 2014
28. Seizing the moment: Zebrafish epilepsy models
- Author
-
Ettore Tiraboschi, Alexander D. Crawford, Kinga Gawel, Wietske van der Ent, Mélanie Langlois, Maxime Jacmin, Camila V. Esguerra, and Teresa G. Martins
- Subjects
0303 health sciences ,Epilepsy ,biology ,Human studies ,Cognitive Neuroscience ,biology.organism_classification ,medicine.disease ,3. Good health ,03 medical and health sciences ,Behavioral Neuroscience ,Disease Models, Animal ,0302 clinical medicine ,Neuropsychology and Physiological Psychology ,Animal model ,Seizures ,medicine ,Animals ,Zebrafish ,Neuroscience ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Zebrafish are now widely accepted as a valuable animal model for a number of different central nervous system (CNS) diseases. They are suitable both for elucidating the origin of these disorders and the sequence of events culminating in their onset, and for use as a high-throughput in vivo drug screening platform. The availability of powerful and effective techniques for genome manipulation allows the rapid modelling of different genetic epilepsies and of conditions with seizures as a core symptom. With this review, we seek to summarize the current knowledge about existing epilepsy/seizures models in zebrafish (both pharmacological and genetic) and compare them with equivalent rodent and human studies. New findings obtained from the zebrafish models are highlighted. We believe that this comprehensive review will highlight the value of zebrafish as a model for investigating different aspects of epilepsy and will help researchers to use these models to their full extent.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.